Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

zimberelimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Solid Tumor, Unspecified, Adult × Clear all
NCT05723640 2025-09-08

The Safety and Dosimetry Study of 177Lu-LNC1004 Injection

Yantai LNC Biotechnology Singapore PTE. LTD.

Phase 1 Completed
11 enrolled
Other solid neoplasm

Solid Tumor, Unspecified, Adult

NCT03628677 2025-02-04

A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies

Arcus Biosciences, Inc.

Phase 1 Completed
75 enrolled
Other solid neoplasm

Solid Tumor, Unspecified, Adult

NCT04976803 2022-08-01

ATM

Artios Pharma Ltd

Completed
229 enrolled
Other solid neoplasm

Solid Tumor, Unspecified, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡